PL2582390T3 - Sposób immunoterapeutyczny obejmujący przeciwciała przeciwko CD123 (IL-3R) oraz kompleks immunostymulacyjny - Google Patents

Sposób immunoterapeutyczny obejmujący przeciwciała przeciwko CD123 (IL-3R) oraz kompleks immunostymulacyjny

Info

Publication number
PL2582390T3
PL2582390T3 PL11794953T PL11794953T PL2582390T3 PL 2582390 T3 PL2582390 T3 PL 2582390T3 PL 11794953 T PL11794953 T PL 11794953T PL 11794953 T PL11794953 T PL 11794953T PL 2582390 T3 PL2582390 T3 PL 2582390T3
Authority
PL
Poland
Prior art keywords
antibodies
method involving
immunostimulating complex
immunotherapeutic method
immunotherapeutic
Prior art date
Application number
PL11794953T
Other languages
English (en)
Inventor
Deborah Pauline Drane
Eugene Maraskovsky
Jefferey Stephen Boyle
Original Assignee
Csl Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Csl Ltd filed Critical Csl Ltd
Publication of PL2582390T3 publication Critical patent/PL2582390T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39558Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55577Saponins; Quil A; QS21; ISCOMS

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL11794953T 2010-06-15 2011-06-15 Sposób immunoterapeutyczny obejmujący przeciwciała przeciwko CD123 (IL-3R) oraz kompleks immunostymulacyjny PL2582390T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35498610P 2010-06-15 2010-06-15
PCT/AU2011/000725 WO2011156860A1 (en) 2010-06-15 2011-06-15 IMMUNOTHERAPEUTIC METHOD INVOLVING CD123 (IL-3Rα) ANTIBODIES AND IMMUNOSTIMULATING COMPLEX
EP11794953.7A EP2582390B1 (en) 2010-06-15 2011-06-15 Immunotherapeutic method involving cd123 (il-3r ) antibodies and immunostimulating complex

Publications (1)

Publication Number Publication Date
PL2582390T3 true PL2582390T3 (pl) 2015-05-29

Family

ID=45347584

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11794953T PL2582390T3 (pl) 2010-06-15 2011-06-15 Sposób immunoterapeutyczny obejmujący przeciwciała przeciwko CD123 (IL-3R) oraz kompleks immunostymulacyjny

Country Status (7)

Country Link
US (1) US8920803B2 (pl)
EP (1) EP2582390B1 (pl)
AU (1) AU2011267837B2 (pl)
DK (1) DK2582390T3 (pl)
ES (1) ES2530977T3 (pl)
PL (1) PL2582390T3 (pl)
WO (1) WO2011156860A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2814962T3 (es) 2013-02-20 2021-03-29 Novartis Ag Fijación eficaz como objetivo de la leucemia humana primaria utilizando células T modificadas con receptor de antígeno quimérico anti-CD123
US10174095B2 (en) 2014-07-21 2019-01-08 Novartis Ag Nucleic acid encoding a humanized anti-BCMA chimeric antigen receptor
RU2020117196A (ru) 2014-08-19 2020-10-15 Новартис Аг Химерный антигенный рецептор (car) против cd123 для использования в лечении злокачественных опухолей
ES2688035T3 (es) 2014-08-29 2018-10-30 Gemoab Monoclonals Gmbh Receptor de antígeno universal que expresa células inmunes para direccionamiento de antígenos múltiples diversos, procedimiento para fabricación del mismo y utilización del mismo para tratamiento de cáncer, infecciones y enfermedades autoinmunes
MY191964A (en) * 2015-01-23 2022-07-21 Sanofi Sa Anti-cd3 antibodies, anti-cd123 antibodies and bispecific antibodies specifically binding to cd3 and/or cd123
EP3280442A4 (en) * 2015-04-08 2018-10-31 Sorrento Therapeutics, Inc. Antibody therapeutics that bind cd123
TW201709932A (zh) * 2015-06-12 2017-03-16 西雅圖遺傳學公司 Cd123抗體及其共軛物
JP7438988B2 (ja) 2018-06-13 2024-02-27 ノバルティス アーゲー Bcmaキメラ抗原受容体及びその使用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6177678B1 (en) 1995-04-05 2001-01-23 Brasscorp Ltd. Method and apparatus for leak detection and non-destructive testing
WO1997024373A1 (en) 1995-12-29 1997-07-10 Medvet Science Pty. Limited Monoclonal antibody antagonists to haemopoietic growth factors
WO2001066139A1 (en) * 2000-03-06 2001-09-13 University Of Kentucky Research Foundation Use of a compound that selectively binds to cd123 to impair hematologic cancer progenitor cell
CA2471092A1 (en) 2001-12-21 2003-07-10 Antigenics Inc. Compositions comprising immunoreactive reagents and saponins, and methods of use thereof
CN101896200A (zh) 2007-12-06 2010-11-24 Csl有限公司 抑制白血病干细胞的方法

Also Published As

Publication number Publication date
AU2011267837B2 (en) 2016-06-23
EP2582390A4 (en) 2013-11-06
WO2011156860A1 (en) 2011-12-22
DK2582390T3 (en) 2015-02-23
US8920803B2 (en) 2014-12-30
US20130149303A1 (en) 2013-06-13
EP2582390A1 (en) 2013-04-24
EP2582390B1 (en) 2014-11-19
ES2530977T3 (es) 2015-03-09
AU2011267837A1 (en) 2013-01-10

Similar Documents

Publication Publication Date Title
IL250624A0 (en) Anti-fgfr3 antibodies and methods of using them
IL250691A0 (en) Anti-ox40 antibodies and methods of using them
ZA201207484B (en) Humanized anti-egfl7 antibodies and methods using same
IL244197A0 (en) Antibodies against cd100 and methods of using them
EP2624066A4 (en) LOADING ELEMENT AND METHOD FOR THE MANUFACTURE THEREOF
IL240898A0 (en) Antibodies against a5c and methods of using the antibodies
PL2606064T3 (pl) Sposoby wytwarzania wieloswoistych i wielowartościowych przeciwciał
HUE037095T2 (hu) Eljárások és reagensek monoklonális ellenanyagok elõállítására
PL2552783T3 (pl) Saszetkarka o dużej szybkości i odpowiedni sposób
PL2582390T3 (pl) Sposób immunoterapeutyczny obejmujący przeciwciała przeciwko CD123 (IL-3R) oraz kompleks immunostymulacyjny
EP2558587A4 (en) METHOD FOR DISPLAYING ANTIBODIES
PL2646466T3 (pl) Środki i sposoby do wytwarzania przeciwciał o wysokim powinowactwie
EP2589815A4 (en) DRIVE AND METHOD FOR THE PRODUCTION THEREOF
PL2621623T3 (pl) Urządzenie i sposób wytwarzania wypełnionych perełek
IL219136A0 (en) Anti-hepsin antibodies and methods using same
GB201010998D0 (en) Sealing method and apparatus
HK1186094A (en) IMMUNOTHERAPEUTIC METHOD INVOLVING CD123 (IL-3Rα) ANTIBODIES AND IMMUNOSTIMULATING COMPLEX
IL218438A0 (en) Humanized antibodies specific for hsp65-derived peptide-6 methods and uses thereof
GB201008325D0 (en) Apparatus and method for searching
GB201008288D0 (en) Search apparatus and method
HK1165434A (en) Humanized anti-egfl7 antibodies and methods using same